Search Results 101-110 of 16124 for chemoprevention

  1. Frank A. Sinicrope, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberChemoprevention Subcommittee, Cancer Control Research Committee, Southwest Oncology Group. 1998 - present. FellowAmerican College of Physicians. 1997 ...

  2. Mammogram guidelines: What's changed? - Mayo Clinic

    See also. Atypical hyperplasia of the breast · Breast cancer · Breast Cancer · Breast cancer chemoprevention · Breast Cancer Education Tool · Common questions ...

  3. A Study of Combination Chemotherapy for Treating Women with Stage II or Stage IIIA Breast Cancer that has Spread to the Lymph Nodes - Mayo Clinic

    No concurrent tamoxifen or other SERMs; Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer ...

  4. Mayo Clinic Comprehensive Cancer Center — Research

    ... chemopreventive regimens. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal ...

  5. Joel M. Reid, Ph.D. - Mayo Clinic Faculty Profiles

    The first chemoprevention phase 0 exploratory pharmacokinetic clinical trial (first-in-man) of the Akt inhibitor SR13668 to establish a formulation with the ...

  6. Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer - Mayo Clinic

    NOTE: Prior use of tamoxifen for chemoprevention is allowed but must be discontinued at study entry. Similarly, prior raloxifene use is allowed but must be ...

  7. Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes - Mayo Clinic

    Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (e.g., ...

  8. Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes - Mayo Clinic

    Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (e.g., ...

  9. Breast cancer staging - Mayo Clinic

    Breast cancer chemoprevention · Breast Cancer Education Tool · Common questions about breast cancer treatment · Breast cancer prevention · Infographic: Breast ...

  10. Weekly dose of erlotinib shows decreased duodenal polyp burden and side effects for patients with FAP - Mayo Clinic

    This study shows the need for further investment in evaluating the use of erlotinib and other chemoprevention therapies for cancer prevention in patients with ...